Gemcitabine (Athenex Pharmaceutical Division, LLC.)
Welcome to the PulseAid listing for the Gemcitabine drug offered from Athenex Pharmaceutical Division, LLC.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Athenex Pharmaceutical Division, LLC. |
| NON-PROPRIETARY NAME: | gemcitabine hydrochloride |
| SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-07-31 |
| END MARKETING DATE: | 0000-00-00 |
Gemcitabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gemcitabine from Athenex Pharmaceutical Division, LLC. |
| LABELER NAME: | Athenex Pharmaceutical Division, LLC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/5mL) |
| START MARKETING DATE: | 2017-07-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70860-204_812a8ac5-60d5-4fde-8b3c-8ca241744f1d |
| PRODUCT NDC: | 70860-204 |
| APPLICATION NUMBER: | ANDA204520 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
